Literature DB >> 22147914

Cullin 3 mediates SRC-3 ubiquitination and degradation to control the retinoic acid response.

Christine Ferry1, Samia Gaouar, Benoit Fischer, Marcel Boeglin, Nicodeme Paul, Eric Samarut, Aleksandr Piskunov, Gabriella Pankotai-Bodo, Laurent Brino, Cecile Rochette-Egly.   

Abstract

SRC-3 is an important coactivator of nuclear receptors including the retinoic acid (RA) receptor α. Most of SRC-3 functions are facilitated by changes in the posttranslational code of the protein that involves mainly phosphorylation and ubiquitination. We recently reported that SRC-3 is degraded by the proteasome in response to RA. Here, by using an RNAi E3-ubiquitin ligase entry screen, we identified CUL-3 and RBX1 as components of the E3 ubiquitin ligase involved in the RA-induced ubiquitination and subsequent degradation of SRC-3. We also show that the RA-induced ubiquitination of SRC-3 depends on its prior phosphorylation at serine 860 that promotes binding of the CUL-3-based E3 ligase in the nucleus. Finally, phosphorylation, ubiquitination, and degradation of SRC-3 cooperate to control the dynamics of transcription. In all, this process participates to the antiproliferative effect of RA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22147914      PMCID: PMC3251120          DOI: 10.1073/pnas.1102572108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

Review 1.  Oncogenic kinase signalling.

Authors:  P Blume-Jensen; T Hunter
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

2.  Multiple Ser/Thr-rich degrons mediate the degradation of Ci/Gli by the Cul3-HIB/SPOP E3 ubiquitin ligase.

Authors:  Qing Zhang; Qing Shi; Yongbin Chen; Tao Yue; Shuang Li; Bing Wang; Jin Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-02       Impact factor: 11.205

3.  Nucleolar targeting of the fbw7 ubiquitin ligase by a pseudosubstrate and glycogen synthase kinase 3.

Authors:  Markus Welcker; Elizabeth A Larimore; Lori Frappier; Bruce E Clurman
Journal:  Mol Cell Biol       Date:  2011-01-10       Impact factor: 4.272

4.  A retinoic acid receptor RARα pool present in membrane lipid rafts forms complexes with G protein αQ to activate p38MAPK.

Authors:  A Piskunov; C Rochette-Egly
Journal:  Oncogene       Date:  2011-11-07       Impact factor: 9.867

5.  Global identification of modular cullin-RING ligase substrates.

Authors:  Michael J Emanuele; Andrew E H Elia; Qikai Xu; Claudio R Thoma; Lior Izhar; Yumei Leng; Ailan Guo; Yi-Ning Chen; John Rush; Paul Wei-Che Hsu; Hsueh-Chi Sherry Yen; Stephen J Elledge
Journal:  Cell       Date:  2011-09-29       Impact factor: 41.582

6.  Evolution of nuclear retinoic acid receptor alpha (RARα) phosphorylation sites. Serine gain provides fine-tuned regulation.

Authors:  Eric Samarut; Ismail Amal; Gabriel V Markov; Roland Stote; Annick Dejaegere; Vincent Laudet; Cécile Rochette-Egly
Journal:  Mol Biol Evol       Date:  2011-02-05       Impact factor: 16.240

7.  Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer.

Authors:  Caryn S Ross-Innes; Rory Stark; Kelly A Holmes; Dominic Schmidt; Christiana Spyrou; Roslin Russell; Charlie E Massie; Sarah L Vowler; Matthew Eldridge; Jason S Carroll
Journal:  Genes Dev       Date:  2010-01-15       Impact factor: 11.361

8.  PEST sequences mediate heat shock factor 2 turnover by interacting with the Cul3 subunit of the Cul3-RING ubiquitin ligase.

Authors:  Hongyan Xing; Yiling Hong; Kevin D Sarge
Journal:  Cell Stress Chaperones       Date:  2009-09-19       Impact factor: 3.667

Review 9.  Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family.

Authors:  Jianming Xu; Ray-Chang Wu; Bert W O'Malley
Journal:  Nat Rev Cancer       Date:  2009-09       Impact factor: 60.716

10.  Tumor-suppressor role for the SPOP ubiquitin ligase in signal-dependent proteolysis of the oncogenic co-activator SRC-3/AIB1.

Authors:  C Li; J Ao; J Fu; D-F Lee; J Xu; D Lonard; B W O'Malley
Journal:  Oncogene       Date:  2011-05-16       Impact factor: 9.867

View more
  14 in total

Review 1.  Transcriptional coregulators: emerging roles of SRC family of coactivators in disease pathology.

Authors:  Subhamoy Dasgupta; Bert W O'Malley
Journal:  J Mol Endocrinol       Date:  2014-07-14       Impact factor: 5.098

Review 2.  Vitamin A and retinoid signaling: genomic and nongenomic effects.

Authors:  Ziad Al Tanoury; Aleksandr Piskunov; Cécile Rochette-Egly
Journal:  J Lipid Res       Date:  2013-02-24       Impact factor: 5.922

Review 3.  Steroid receptor coactivator-3 as a potential molecular target for cancer therapy.

Authors:  Jean Ching-Yi Tien; Jianming Xu
Journal:  Expert Opin Ther Targets       Date:  2012-08-27       Impact factor: 6.902

Review 4.  The emerging family of CULLIN3-RING ubiquitin ligases (CRL3s): cellular functions and disease implications.

Authors:  Pascal Genschik; Izabela Sumara; Esther Lechner
Journal:  EMBO J       Date:  2013-08-02       Impact factor: 11.598

Review 5.  Cullin 3-Based Ubiquitin Ligases as Master Regulators of Mammalian Cell Differentiation.

Authors:  Wolfgang Dubiel; Dawadschargal Dubiel; Dieter A Wolf; Michael Naumann
Journal:  Trends Biochem Sci       Date:  2017-12-14       Impact factor: 13.807

Review 6.  Retinoids induce stem cell differentiation via epigenetic changes.

Authors:  Lorraine J Gudas
Journal:  Semin Cell Dev Biol       Date:  2013-08-21       Impact factor: 7.727

Review 7.  SRC-3, a Steroid Receptor Coactivator: Implication in Cancer.

Authors:  Licen Li; Chu-Xia Deng; Qiang Chen
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

8.  The ATRA-induced differentiation of medulloblastoma cells is enhanced with LOX/COX inhibitors: an analysis of gene expression.

Authors:  Petr Chlapek; Jakub Neradil; Martina Redova; Karel Zitterbart; Jaroslav Sterba; Renata Veselska
Journal:  Cancer Cell Int       Date:  2014-06-13       Impact factor: 5.722

Review 9.  Increasing the Content of High-Content Screening: An Overview.

Authors:  Shantanu Singh; Anne E Carpenter; Auguste Genovesio
Journal:  J Biomol Screen       Date:  2014-04-07

10.  Peroxisome proliferator-activated receptor gamma and regulations by the ubiquitin-proteasome system in pancreatic cancer.

Authors:  Athina Stravodimou; Gianluigi Mazzoccoli; Ioannis A Voutsadakis
Journal:  PPAR Res       Date:  2012-09-19       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.